T cells continuously recirculate between lymphoid organs via the blood and lymphatic systems, entering lymph nodes through specialized high endothelial venules (HEVs) 1 . Initial selectin-mediated interactions result in rolling of T cells on the endothelium. Subsequently, signaling by chemokine CCL21 through its receptor CCR7 on T cells leads to the activation of cell-surface integrin adhesion molecules such as LFA-1 (α L β 2 ), which binds to its ligands ICAM1 and ICAM2, leading to firm adhesion between the T cell and HEV. T cells then transmigrate across the endothelium and enter the parenchyma of the lymph node, where they migrate rapidly under the influence of the CCR7 ligands CCL19 and CCL21, a process that is much less dependent on integrins 2-4 . Finally, T cells exit lymph nodes through lymphatic vessels and return to circulation via the venous system. This recirculation is critical for allowing T cells to scan lymphoid tissue for antigen-presenting cells (APCs) bearing cognate antigen in the form of a complex of peptide and major histocompatibility complex that can bind to the T cell antigen receptor (TCR). Binding of antigen to the TCR results in signaling that stops T cell migration and activates LFA-1, causing firm adhesion between the T cell and the APC. The formation of such T cell-APC conjugates is necessary for T cell activation and initiation of T cell immune responses.
and its ligands need to be immobilized, such that binding of ligand to LFA-1 results in the exertion of force.
Inside-out signals from the TCR result in LFA-1 activation through similar mechanisms; however, in the absence of immobilized ligand, they do not change the integrin conformation 8 . Once again, for stable adhesion, the ligand needs to be immobilized on the APC, and LFA-1 needs to be anchored to the actin cytoskeleton such that binding of LFA-1 to ICAM1 results in a force that promotes high-affinity binding. A critical signaling molecule that transduces inside-out signals from both chemokine receptors and the TCR is the GTPase RAP1 (ref. 5) . Active RAP1-GTP binds to the effector proteins RIAM and RAPL, which in turn promote binding of talin to the β-subunit of LFA-1 and clustering of LFA-1, respectively [9] [10] [11] .
To identify additional proteins that might contribute to the activation of LFA-1, we used an RNA-mediated interference (RNAi) screen to identify kinases that regulate integrin-dependent binding of T cells to APCs. We found that the kinase WNK1 is a negative regulator of both chemokine-receptor-and TCR-induced activation of LFA-1 and subsequent adhesion and that it does so via RAP1. Conversely, we found that WNK1 is a positive regulator of T cell migration through the kinases OXSR1 and STK39 and the ion co-transporter SLC12A2. In the absence of WNK1, T cells home less efficiently to lymphoid organs and migrate more slowly through them. Our results reveal that a pathway previously shown to regulate salt homeostasis in the kidney 12,13 also functions to balance T cell adhesion and migration.
RESULTS

WNK1 is a negative regulator of integrin-mediated adhesion
To identify previously unknown signaling pathways that regulate the adhesion of T cells, we carried out an RNAi screen in which 1 0 7 6 VOLUME 17 NUMBER 9 SEPTEMBER 2016 nature immunology A r t i c l e s we knocked down expression of 719 genes encoding kinases and kinase-related molecules individually in the Jurkat human T cell leukemia cell line and analyzed the ability of the cells to form antigen-specific conjugates with the Nalm6 B cell line in response to the superantigen staphylococcal enterotoxin E (SEE) (data not shown). One of the validated hits from the screen was WNK1, which encodes the serine-threonine kinase WNK1; the knockdown of WNK1 resulted in increased T cell-B cell conjugation. Jurkat T cells with reduced amounts of WNK1 exhibited increased conjugation across a broad range of SEE concentrations ( Fig. 1a and Supplementary Fig. 1a,b) . In contrast, knockdown of the tyrosine kinase LCK, a critical positive regulator of TCR signaling, resulted in decreased conjugation (Fig. 1a) .
Antigen-induced adhesion between T cells and APCs is mediated mainly by binding of integrins such as LFA-1 on T cells to their ligands such as ICAM1 on APCs 14 . To test whether the increased T cell-APC conjugation observed in WNK1-deficient Jurkat T cells was caused by increased TCR-induced integrin-mediated adhesion, we evaluated the ability of the cells to bind ICAM1 complexes and to adhere to plate-bound ICAM1. In addition, we broadened the (g) Immunoblot analysis (top) of RAP1 and RAP1-GTP precipitated from Jurkat T cells transfected with non-targeting or WNK1-specific siRNA (above blots) and stimulated for various times (above lanes) with CXCL12 or anti-CD3; below, abundance of RAP1-GTP relative to that of RAP1. (h) Immunoblot analysis of RAP1 and RAP1-GTP precipitated from mouse CD4 + T cells stimulated for various times (above lanes) with CCL21 or anti-CD3 (below, quantification as in g). *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (two-way analysis of variance (ANOVA) (a-c), Mann-Whitney test (d,e) or unpaired t test (f-h)). Sample sizes: a (three), b (four, control; six, mutant), c (six), d (five), e (six, control; five, mutant), f (six; except three in rightmost panel), g (four), h (four). Data are from one experiment representative of three (a-c,e, and f, far right) or four (g,h) experiments (mean ± s.e.m.) or are pooled from two independent experiments (d, and f, leftmost three panels; mean + s.e.m.).
study by investigating the effect of WNK1 deficiency on chemokineinduced integrin-mediated adhesion. We found that knockdown of WNK1 resulted in increased adhesion of Jurkat T cells to both soluble ICAM1 and plate-bound ICAM1 following stimulation through either the chemokine receptor CXCR4 or the TCR, despite there being no alteration in surface expression of CXCR4, TCR or LFA-1 ( Fig. 1b and Supplementary Fig. 1c-f) . In contrast, knockdown of LCK resulted in decreased adhesion. Notably, time-course analysis revealed that the binding of ICAM1 was already significantly increased in WNK1-deficient Jurkat T cells 15 s or 1 min after stimulation through CXCR4 or TCR, respectively, which suggested that WNK1 is involved in the early stages of adhesion.
To investigate whether WNK1 also regulates adhesion in primary T cells, we generated mice with WNK1-deficient T cells, using either the dLck-Cre transgene 15 , for conditional deletion of a loxP-flanked allele of Wnk1 (Wnk1 fl ) 16 at late stages of thymocyte development, or ROSA26-CreERT2 (RCE), a tamoxifen-inducible Cre recombinase 17 . We generated bone marrow chimeras by reconstituting irradiated mice deficient in the RAG1 recombinase (which lack mature B cells and T cells) with marrow cells from either strain. This served to increase the number of mice from which WNK1-deficient T cells could be isolated and, for the Wnk1 fl/-RCE strain, it limited the complete loss of Wnk1 to lymphocytes. In both strains, there was efficient loss of Wnk1 mRNA in CD4 + T cells and CD8 + T cells ( Supplementary Fig. 2a-c) . We found that in response to stimulation through either CCR7 or the TCR, WNK1-deficient CD4 + T cells showed increased binding of ICAM1 complexes and increased adhesion to ICAM1-coated plates (Fig. 1c,d) . Furthermore, consistent with increased TCR-induced adhesion through LFA-1, the mutant T cells were more efficient at forming antigen-specific conjugates with APCs (Fig. 1e) . Mutant T cells had slightly reduced surface expression of TCR and CCR7, but slightly elevated expression of LFA-1 ( Supplementary Fig. 2d,e) . Once again, time-course analysis revealed increased ICAM1 binding at all time points following stimulation through CCR7 or TCR. Thus, as in Jurkat T cells, WNK1 is a negative regulator of both chemokinereceptor-and TCR-induced integrin-dependent adhesion in primary mouse T cells and acts at the earliest stages of adhesion.
WNK1 is a negative regulator of RAP1 Next we investigated the mechanism by which WNK1 regulates integrin-mediated adhesion. Using antibodies that recognize either an intermediate-affinity conformation of human LFA-1 or high-affinity conformation of human LFA-1, we were able to detect an increase in both of these conformations on Jurkat T cells in response to CXCL12 (Fig. 1f) . In contrast, as expected 8 , stimulation of the cells through the TCR resulted in no detectable change in LFA-1 affinity (Fig. 1f) . Notably, the CXCL12-induced increase in intermediate-or high-affinity LFA-1 conformations was not affected by a loss of WNK1 (Fig. 1f) ; thus, WNK1 does not regulate the chemokine-induced affinity change in LFA-1. In contrast, we noted increased adhesion to ICAM1 in both WNK1-deficient Jurkat cells and primary mouse T cells in response to Mn 2+ , a cation that directly induces the high-affinity conformation of LFA-1 (Fig. 1b,c,f) . This suggests that WNK1 may regulate other processes that contribute to LFA-1-mediated adhesion, such as anchoring of the integrin to the actin cytoskeleton or its clustering.
We extended the analysis to intracellular signaling pathways and found no change in chemokine-or TCR-induced activation of ERK kinases, no change in TCR-induced calcium fluxes in WNK1-deficient Jurkat T cells, and no change in chemokine-induced actin polymerization in WNK1-deficient mouse CD4 + T cells ( Supplementary  Fig. 3a-c) . However, both Jurkat T cells and primary mouse CD4 + T cells deficient in WNK1 showed a large increase in both chemokineand TCR-induced activation of RAP1, a critical regulator of integrinmediated adhesion 5, 14 (Fig. 1g,h and Supplementary Fig. 1g ). Given published studies showing that expression of constitutively active RAP1 in T cells results in increased integrin-mediated adhesion 18 , we conclude that WNK1 may act as a negative regulator of RAP1 activation and thereby influence integrin-mediated adhesion.
WNK1 is a positive regulator of T cell migration
Given that the processes of T cell adhesion and migration are closely related, with increased adhesion potentially leading to decreased migration 19 , we also examined the effect of WNK1 knockdown on cell migration using a Transwell assay. We found that WNK1-deficient Jurkat T cells migrated less efficiently in response to the chemokine CXCL12, despite expressing normal levels of CXCR4 ( Fig. 2a and Supplementary Fig. 1f,h ). Furthermore, WNK1-deficient primary mouse CD4 + T cells also showed less-efficient chemotaxis in response to a gradient of CCL21 in both the absence of ICAM1 and presence of ICAM1 and showed less chemokinesis in response to equal concentrations of CCL21 below and above the membrane (Fig. 2b) . Timelapse imaging revealed that in response to CCL21, WNK1-deficient WNK1 is required for efficient homing into lymph nodes Next we evaluated whether WNK1 also regulates physiological T cell trafficking. We transferred a mixture of WNK1-expressing T cells and WNK1-deficient T cells intravenously into wild-type mice and analyzed their homing into lymphoid organs. We found that WNK1-deficient CD4 + and CD8 + T cells homed less efficiently into both lymph nodes and the spleen 1 h after transfer, with more cells remaining in the blood (Fig. 3a) . Three-dimensional histological analysis revealed that a larger fraction of the mutant T cells were located in the lumen of the blood vessels and in perivascular regions of the lymph nodes 20 or 40 min after transfer, whereas fewer had entered npg the parenchyma (Fig. 3b and Supplementary Video 2) ; this suggested that WNK1-deficient T cells were less efficient at extravasating across the endothelium and at migrating away from the vasculature into the parenchyma. Similarly, histology of the spleen showed that more WNK1-deficient T cells were located in the red pulp than in the white pulp, where most T cells reside, at 1 h after transfer (Fig. 3c) , which suggests that WNK1-deficient T cells are defective at crossing the marginal sinus-lining cells that lymphocytes need to cross to gain entry to the white pulp. To delineate the integrin-dependent adhesion and transmigration steps required for entry into lymph nodes, we imaged control and mutant T cells migrating on a monolayer of endothelial cells under flow and transmigrating through it 20 . We found that WNK1-deficient T cells arrested for a longer fraction of time on the endothelial cells and more of them resisted detachment from endothelial cells (Fig. 3d,e and Supplementary Video 3) , consistent with their hyperadhesive phenotype. Conversely, fewer mutant T cells were able to cross through the endothelial monolayer, and they took longer to do so (Fig. 3f) . Furthermore, the mutant T cells migrated more slowly on the endothelial monolayer (Fig. 3g) . Finally, we transferred either control or mutant T cells into wildtype mice and used intravital imaging to follow their movement in the lumen of the HEV and in the parenchyma of lymph nodes. Imaging of rapid T cell adhesion in lymph node HEVs showed a similar sticking fraction of firmly adherent cells for both WNK1-deficient T cells and control T cells (Fig. 4a) , which suggests that the absence of WNK1 does not affect the ability of T cells to adhere firmly to endothelium. In contrast, analysis of cells in the parenchyma of the lymph nodes revealed that WNK1-deficient T cells migrated more slowly than did control T cells, had a lower motility coefficient (66.7 µm 2 /min and 34.5 µm 2 /min in control and mutant cells, respectively) and were more rounded (Fig. 4b-e and Supplementary Video 4) . To evaluate whether this reduced migration was caused by increased integrinmediated adhesion, we transferred T cells into wild-type mice and then blocked the integrins LFA-1 and VLA-4 15-18 h later. We found that WNK1-deficient T cells still migrated more slowly than did control T cells, had a reduced motility coefficient (22.4 µm 2 /min (control cells) and 3.4 µm 2 /min (mutant cells)) and displayed larger turning angles, a characteristic feature of slower migrating cells 21 (Fig. 4c,d and Supplementary Fig. 4) . Indeed, the mutant cells migrated even more slowly in the presence of integrin-blocking antibodies (Fig. 4c) , which indicated that their decreased migration speed was not a result of hyperadhesiveness via integrins. Thus, we conclude that WNK1 is Chemokine receptors and TCR activate the WNK1 pathway Although WNK1 has not been studied in lymphocytes, its function has been extensively investigated in kidney tubular epithelial cells, in which it controls the uptake of sodium, potassium and chloride ions 12 . In particular, WNK1 phosphorylates and activates two related kinases, OXSR1 and STK39, which in turn phosphorylate and activate the Na + -K + -Cl − co-transporters SLC12A2 (NKCC1) and SLC12A1 (NKCC2) and thereby stimulate uptake of these ions 22 . In view of the unexpected role for WNK1 in T cell adhesion and migration, we sought to determine whether the pathway that leads from WNK1 and branches into OXSR1 or STK39, either of which then leads to SLC12A2 or SLC12A1 (WNK1-OXSR1/STK39-SLC12A2/SLC12A1), might also function in T cells and, if so, whether it might contribute to the adhesion and migration of the cells. Analysis of RNA-sequencing data revealed that both CD4 + primary mouse T cells and CD8 + primary mouse T cells expressed Wnk1 but not other members of the Wnk family (Fig. 5a ). Both subsets of T cells also expressed Oxsr1, Stk39 and Slc12a2, but not Slc12a1 (Fig. 5a) . To investigate whether the WNK1-OXSR1/STK39-SLC12A2 pathway functions in T cells, we stimulated primary mouse CD4 + T cells through CCR7 or the TCR and immunoblotted cell extracts with antibodies specific for WNK1-phosphorylation sites on OXSR1 and STK39 (Ser325 and Ser383, respectively) 23 . We found that each stimulus resulted in rapid phosphorylation of OXSR1, which was abrogated in WNK1-deficient T cells (Fig. 5b,c) . Thus, both CCR7 and the TCR transduce signals through WNK1, which lead to the phosphorylation and, presumably, activation of OXSR1.
To evaluate whether WNK1's kinase activity is required for its regulation of T cell adhesion and migration, we generated a strain of mice with replacement of the aspartic acid at position 368 with alanine (D368A) in the kinase domain of the protein, a change that had been shown to eliminate kinase activity 23 (Supplementary Fig. 5a ). Mice homozygous for this Wnk1 D368A allele did not survive to birth (Supplementary Fig. 5b ), similar to results previously reported for mice with total loss of WNK1 (ref. 24) . To analyze T cells expressing only kinase-inactive WNK1, we generated compound heterozygous mice with both a loxP-flanked allele of Wnk1 and a kinase-inactive allele of Wnk1, and tamoxifen-inducible Cre (Wnk1 fl/D368A RCE); treatment of such mice with tamoxifen results in T cells that express only kinase-inactive WNK1. As a control, we used Wnk1 fl/+ RCE mice, in which tamoxifen injection leads to deletion of the conditional allele of Wnk1, leaving an intact wild-type allele. T cells from both strains express similar amounts of Wnk1 (Supplementary Fig. 5c ).
T cells expressing kinase-inactive WNK1 had much less phosphorylation of OXSR1 and showed no inducible phosphorylation of OXSR1 in response to stimulation through either CCR7 or the TCR (Fig. 5d) . These results indicate that the kinase activity of WNK1 is required for the transduction of signals via CCR7 and the TCR, which lead to phosphorylation of OXSR1 at Ser325. Given that this site is a known substrate of WNK1, our findings suggest that signaling via both CCR7 and the TCR leads to activation of WNK1's kinase activity. 
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CCR7 and TCR activate WNK1 via PI(3)K and AKT
We next investigated how CCR7 and the TCR might activate WNK1, despite engaging largely different signaling pathways. Published studies have suggested that AKT might activate WNK1 (ref. 25) , and given that both chemokine receptors and the TCR are known to activate AKT via phosphatidylinositol-4,5-bisphosphate 3-kinase (PI(3)K), we assessed the potential involvement of these kinases in the activation of WNK1. We found that treatment of T cells with PI-103 or MK2206 (inhibitors of PI(3)K or AKT, respectively) blocked both CCR7-and TCR-induced phosphorylation of AKT and PRAS40, a known substrate of AKT, indicating that both inhibitors were acting as expected (Fig. 5e) . Notably, both inhibitors also blocked CCR7-and TCR-induced phosphorylation of OXSR1 (Fig. 5e) . Together these results suggest that both receptors transduce signals via PI(3)K and AKT, which lead to the activation of WNK1.
WNK1's kinase activity regulates adhesion and migration Finally, we investigated whether WNK1's kinase activity is required for the regulation of integrin-mediated adhesion or migration in T cells. We found that CD4 + T cells expressing kinase-inactive WNK1 showed increased binding of ICAM1 following stimulation through CCR7 or TCR and in response to treatment with Mn 2+ to activate integrins from the outside (Fig. 5f) , and they showed decreased CCL21-induced migration (Fig. 5g) . These results are very similar to those obtained for WNK1-deficient T cells and indicate that the kinase activity of WNK1 is required for its negative regulation of integrin-mediated adhesion and positive regulation of migration.
OXSR1, STK39 and SLC12A2 do not regulate adhesion via LFA-1 We next investigated whether the OXSR1/STK39-SLC12A2 pathway, the best-characterized pathway downstream of WNK1, is also involved in the processes assessed above. Knockdown of OXSR1 or STK39 alone, both OXSR1 and STK39 together, or SLC12A2 in Jurkat T cells had no effect on CCR7-or TCR-induced binding of ICAM1 complexes or adhesion to plate-bound ICAM1, or on conjugation of Jurkat T cells to SEE-pulsed APCs (Fig. 6a,b , and Supplementary   Fig. 1a,e) . Extending these studies to primary mouse T cells, we investigated CD4 + T cells from mice bearing a point mutation in Oxsr1 that results in replacement of the threonine at position 185 with alanine (T185A) 13 . This residue is phosphorylated by WNK1, which leads to activation of OXSR1 (ref. 22) , and OXSR1-T185A can therefore no longer be activated by WNK1. We also assessed SLC12A2-deficient CD4 + T cells 26 . We found that T cells expressing OXSR1-T185A or deficient in SLC12A2 showed no alteration in CCR7-, TCR-or Mn 2+ -induced binding of ICAM1 complexes (Fig. 6c,d) . Thus, although the WNK1 kinase is a negative regulator of integrin-mediated adhesion, it does not do this through OXSR1, STK39 or SLC12A2.
OXSR1, STK39 and SLC12A2 regulate migration
In contrast with the lack of effect on adhesion, knockdown of OXSR1 or STK39 alone, both together, or SLC12A2 resulted in reduced CCL21-induced chemotaxis of Jurkat T cells ( Fig. 7a and Supplementary Fig. 1h ). Furthermore, CCL21-induced chemotaxis was decreased in mouse CD4 + T cells expressing OXSR1-T185A or deficient in SLC12A2 (Fig. 7b,c) , and time-lapse imaging revealed that SLC12A2-deficient T cells migrated more slowly in response to CCL21 (Fig. 7d and Supplementary Video 5) , despite unaltered surface expression of CCR7 (Supplementary Fig. 2f,g ). Finally, we sought to determine whether the movement of ions through the co-transporter SLC12A2 is required for its function in T cell migration by treating cells with bumetanide, an inhibitor of ion transport by SLC12A2. We found that bumetanide decreased the CCL21-induced chemotaxis of wild-type CD4 + T cells, although the decrease was not as large as that in WNK1-deficient T cells (Fig. 7e) . Together, these results suggest that WNK1 regulates T cell migration via the OXSR1-STK39-SLC12A2 pathway and that it does so in part by controlling ion movement through SLC12A2.
DISCUSSION
Using an RNAi screen, we identified a previously unknown pathway that regulates T cell adhesion and migration in vivo. WNK1 has been shown to control salt reabsorption in the kidney, in part through A r t i c l e s activation of OXSR1 and STK39 and the co-transporters SLC12A2 and SLC12A1 (ref. 22 ). Thus, it was surprising to find that WNK1 regulates T cell adhesion, that the WNK1-OXSR1/STK39-SLC12A2 pathway controls cell migration, and that this pathway is activated by stimulation of the cells through the TCR or CCR7. Our results suggest that both receptors transduce signals via PI(3)K and AKT, which lead to the rapid activation of WNK1. AKT has been reported to phosphorylate WNK1 at Thr60 (refs. 27,28); however, this phosphorylation does not lead to activation of WNK1's kinase activity, so it remains unclear how AKT activates WNK1. We found that WNK1 is a negative regulator of LFA-1-mediated adhesion and that WNK1's kinase activity is required for this function. WNK1 does not regulate chemokine-induced conformational changes of LFA-1. Instead, we found that WNK1-deficient cells had a large increase in activated RAP1, which we propose might be responsible for the increased adhesion. Consistent with this, T cells expressing a constitutively active RAP1 are hyperadhesive 18 , including after treatment with Mg 2+ and EGTA, which induces a high-affinity conformation of LFA-1 similar to Mn 2+ treatment. Thus the increased RAP1-GTP in WNK1-deficient T cells might account for the increased adhesion in response to Mn 2+ . Active RAP1-GTP binds to the effector proteins RIAM and RAPL, which in turn induce binding of talin to the β-subunit of LFA-1 and clustering of LFA-1, respectively, thereby promoting adhesion [9] [10] [11] . It is unclear how WNK1 might regulate RAP1 activation, but it is possible that it directly or otherwise regulates RAP1-specific guanine nucleotide exchange factors or GTPase-activating proteins.
Our results also indicate that WNK1 is a positive regulator of T cell migration in response to chemokines. This migration function required WNK1's kinase activity but was distinct from its role as a negative regulator of adhesion for two reasons. First, genetic studies revealed that the OXSR1/STK39-SLC12A2 pathway downstream of WNK1 is required for the regulation of migration, but not adhesion. Second, if the reduced migration of WNK1-deficient T cells were a result of increased adhesion, blocking adhesion should have allowed mutant T cells to migrate more rapidly. However, intravital imaging of T cells in lymph nodes revealed that blocking integrin binding did not cause WNK1-deficient T cells to speed up; on the contrary, they migrated even more slowly, which suggests that their hyperadhesive phenotype partially 'rescues' the migration defect. Our results indicate that WNK1 regulates migration through the OXSR1/STK39-SLC12A2 pathway and that at least part of this might be mediated by the movement of ions across the membrane through SLC12A2. One possibility is that ion transport contributes to cell migration by causing osmotic uptake of water, which results in changes in cell volume that are required for cell movement 29 . In this context, we note the proposed 'osmotic engine model' , in which polarized uptake of ions and water at the leading edge of a cell and efflux of ions and water at the trailing edge result in cell movement 30 . In support of the proposed role for SLC12A2 in cell migration, this co-transporter localizes to the leading edge of migrating glioma cells, and inhibition of its iontransport function results in reduced migration 31 . Future studies should investigate localization of the proteins in the WNK1-OXSR1/ STK39-SLC12A2 pathway in migrating T cells. Finally, we note that the 'adhesome' of fibroblasts shows enrichment for WNK1 and WNK1 expression is upregulated in migrating fibroblasts, which suggests that it might be involved in these processes in other cell types 32, 33 .
In summary, we have identified WNK1 as a previously unknown regulator of T cell adhesion and migration that, to the best of our knowledge, is the first regulator of its kind to inversely control these two processes. In contrast, for example, T cells deficient in the GTPases RAC1 and RAC2 show a decrease in both integrinmediated adhesion and migration 34 . T cells with hyperactive LFA-1 show increased adhesiveness but reduced migration 35, 36 ; however, this reduction in migration is a consequence of hyperadhesiveness and seen only in the presence of integrin ligands, whereas interstitial migration in lymph nodes is unaffected. In contrast, loss of WNK1 results in increased adhesion and decreased migration, but the latter phenotype is independent of the adhesion phenotype. Thus, WNK1 inversely and independently regulates adhesion and migration and may act to balance these two related processes.
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